vs
HomeTrust Bancshares, Inc.（HTB）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
HomeTrust Bancshares, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.5倍（$53.6M vs $35.5M），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 3.7%），HomeTrust Bancshares, Inc.自由现金流更多（$45.3M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 3.5%）
HomeTrust Bancshares, Inc.是总部位于美国北卡罗来纳州阿什维尔的银行控股公司，总资产达43亿美元，在北卡、南卡、佐治亚和田纳西州共设有33家网点，旗下拥有HomeTrust银行、Tryon联邦银行等七家社区银行。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
HTB vs RXRX — 直观对比
营收规模更大
HTB
是对方的1.5倍
$35.5M
营收增速更快
RXRX
高出678.1%
3.7%
自由现金流更多
HTB
多$92.6M
$-47.3M
两年增速更快
RXRX
近两年复合增速
3.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $53.6M | $35.5M |
| 净利润 | — | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 37.0% | -304.8% |
| 净利率 | — | -304.2% |
| 营收同比 | 3.7% | 681.7% |
| 净利润同比 | — | 39.6% |
| 每股收益（稀释后） | $0.93 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HTBRXRX
| Q4 25 | $53.6M | $35.5M | ||
| Q3 25 | $54.1M | $5.2M | ||
| Q2 25 | $54.4M | $19.2M | ||
| Q1 25 | $50.9M | $14.7M | ||
| Q4 24 | $51.7M | $4.5M | ||
| Q3 24 | $50.6M | $26.1M | ||
| Q2 24 | $50.6M | $14.4M | ||
| Q1 24 | $50.0M | $13.8M |
净利润HTBRXRX
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $16.5M | $-162.3M | ||
| Q2 25 | $17.2M | $-171.9M | ||
| Q1 25 | $14.5M | $-202.5M | ||
| Q4 24 | — | $-178.9M | ||
| Q3 24 | $13.1M | $-95.8M | ||
| Q2 24 | $12.4M | $-97.5M | ||
| Q1 24 | $15.1M | $-91.4M |
毛利率HTBRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率HTBRXRX
| Q4 25 | 37.0% | -304.8% | ||
| Q3 25 | 38.5% | -3327.6% | ||
| Q2 25 | 40.1% | -916.8% | ||
| Q1 25 | 36.2% | -1297.9% | ||
| Q4 24 | 35.4% | -4042.4% | ||
| Q3 24 | 33.2% | -377.1% | ||
| Q2 24 | 31.3% | -697.4% | ||
| Q1 24 | 38.0% | -698.4% |
净利率HTBRXRX
| Q4 25 | — | -304.2% | ||
| Q3 25 | 30.5% | -3135.3% | ||
| Q2 25 | 31.6% | -894.2% | ||
| Q1 25 | 28.5% | -1373.3% | ||
| Q4 24 | — | -3935.5% | ||
| Q3 24 | 25.9% | -367.5% | ||
| Q2 24 | 24.6% | -676.6% | ||
| Q1 24 | 30.1% | -662.4% |
每股收益（稀释后）HTBRXRX
| Q4 25 | $0.93 | $-0.17 | ||
| Q3 25 | $0.95 | $-0.36 | ||
| Q2 25 | $1.00 | $-0.41 | ||
| Q1 25 | $0.84 | $-0.50 | ||
| Q4 24 | $0.83 | $-0.56 | ||
| Q3 24 | $0.76 | $-0.34 | ||
| Q2 24 | $0.73 | $-0.40 | ||
| Q1 24 | $0.88 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $324.7M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $600.7M | $1.1B |
| 总资产 | $4.5B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资HTBRXRX
| Q4 25 | $324.7M | $743.3M | ||
| Q3 25 | $315.8M | $659.8M | ||
| Q2 25 | $297.2M | $525.1M | ||
| Q1 25 | $299.8M | $500.5M | ||
| Q4 24 | $279.2M | $594.4M | ||
| Q3 24 | $293.5M | $427.6M | ||
| Q2 24 | $294.2M | $474.3M | ||
| Q1 24 | $380.5M | $296.3M |
总债务HTBRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益HTBRXRX
| Q4 25 | $600.7M | $1.1B | ||
| Q3 25 | $595.8M | $1.0B | ||
| Q2 25 | $579.3M | $919.1M | ||
| Q1 25 | $565.4M | $933.9M | ||
| Q4 24 | $551.8M | $1.0B | ||
| Q3 24 | $540.0M | $524.6M | ||
| Q2 24 | $523.6M | $584.4M | ||
| Q1 24 | $513.2M | $401.2M |
总资产HTBRXRX
| Q4 25 | $4.5B | $1.5B | ||
| Q3 25 | $4.6B | $1.4B | ||
| Q2 25 | $4.6B | $1.3B | ||
| Q1 25 | $4.6B | $1.3B | ||
| Q4 24 | $4.6B | $1.4B | ||
| Q3 24 | $4.6B | $726.5M | ||
| Q2 24 | $4.7B | $775.9M | ||
| Q1 24 | $4.7B | $557.8M |
负债/权益比HTBRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $49.5M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $45.3M | $-47.3M |
| 自由现金流率自由现金流/营收 | 84.5% | -133.1% |
| 资本支出强度资本支出/营收 | 7.8% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $93.8M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流HTBRXRX
| Q4 25 | $49.5M | $-46.1M | ||
| Q3 25 | $-11.3M | $-117.4M | ||
| Q2 25 | $-8.8M | $-76.4M | ||
| Q1 25 | $71.7M | $-132.0M | ||
| Q4 24 | $45.4M | $-115.4M | ||
| Q3 24 | $43.8M | $-59.2M | ||
| Q2 24 | $5.9M | $-82.2M | ||
| Q1 24 | $-9.0M | $-102.3M |
自由现金流HTBRXRX
| Q4 25 | $45.3M | $-47.3M | ||
| Q3 25 | $-12.0M | $-117.6M | ||
| Q2 25 | $-10.2M | $-79.6M | ||
| Q1 25 | $70.7M | $-133.8M | ||
| Q4 24 | $42.4M | $-116.7M | ||
| Q3 24 | $43.1M | $-63.8M | ||
| Q2 24 | $5.7M | $-83.4M | ||
| Q1 24 | $-9.6M | $-109.0M |
自由现金流率HTBRXRX
| Q4 25 | 84.5% | -133.1% | ||
| Q3 25 | -22.2% | -2272.5% | ||
| Q2 25 | -18.7% | -413.9% | ||
| Q1 25 | 138.7% | -907.4% | ||
| Q4 24 | 82.0% | -2567.7% | ||
| Q3 24 | 85.1% | -244.6% | ||
| Q2 24 | 11.2% | -578.5% | ||
| Q1 24 | -19.2% | -789.9% |
资本支出强度HTBRXRX
| Q4 25 | 7.8% | 3.5% | ||
| Q3 25 | 1.4% | 4.7% | ||
| Q2 25 | 2.5% | 16.4% | ||
| Q1 25 | 2.0% | 12.4% | ||
| Q4 24 | 5.9% | 28.6% | ||
| Q3 24 | 1.3% | 17.5% | ||
| Q2 24 | 0.5% | 8.2% | ||
| Q1 24 | 1.1% | 48.2% |
现金转化率HTBRXRX
| Q4 25 | — | — | ||
| Q3 25 | -0.68× | — | ||
| Q2 25 | -0.51× | — | ||
| Q1 25 | 4.93× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.34× | — | ||
| Q2 24 | 0.48× | — | ||
| Q1 24 | -0.60× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
